CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 14 No. 3 3
 

Gated 4D PET/CT: Improving Radiation Treatment Planning for Patients With Lung Cancer

By ROY S. HERBST, MD, PhD
The University of Texas
M . D. Anderson Cancer Center
Houston, Texas
| March 1, 2005

TEANECK, New Jersey-Respiratory gating during positron emission tomography (PET) and computed tomography (CT) can reduce uncertainties about tumor location, thereby improving radiation treatment planning for patients with lung cancer, according to a pilot study presented at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (abstract 1056). "We have been using PET/CT at our facility for about 3 years now, so we are very comfortable using functional imaging with PET in treatment planning for radiation oncology," said lead author Allan J. Caggiano, MS, a medical physicist at Holy Name Hospital, Teaneck, New Jersey. "We decided to try to extend this technology to include imaging the patients while they are breathing, trying to eliminate some of the errors associated with moving tumors under respiration," he told Oncology News International in an interview. Two-Day Protocol Eighteen patients with lung cancer have participated in the 2-day protocol. On the first day, an immobilization device was made, patients were trained in regular breathing, and baseline measures were obtained; on the second day, ungated and gated (4D) PET/CT images were obtained, the latter during coached breathing. Treatment plans were generated from both ungated and gated PET/ CTs. Tumor motion on gated PET/ CTs was assessed during 10 phases of respiration, ranging from one full inhalation to the next, and was classified as low (< 1.0 cm), medium (1.0 to 2.0 cm), or high (> 2.0 cm). Overall, 15 (83%) of the 18 patients completed the rigorous imaging protocol. The gated PET and CT images were successfully fused for each of the 10 respiratory phases, and the phases were then combined into a movie loop. Analyzing Tumor Motion Analysis showed that tumor centroids moved 0 to 3.0 cm during breathing, and one-third of patients each had tumors with high, medium, and low motion. This information is useful because patients who fall into the low-motion group probably do not need any kind of gated treatment, Mr. Caggiano noted. Not surprisingly, most of the tumor motion occurred in the superior-inferior direction. Clinicians reported that having the gated PET/CT movie loops helped in planning radiation therapy and identifying patients who were good candidates for respiratory-gated radiation therapy. "We found that at least about 50% of the patients benefited from our knowing ahead of time what the movement was so we could establish that in our treatment margins," Mr. Caggiano said. "This is a very different approach from what we have done in the past, which was to look at how we thought the tumor was moving in general for people and then just [expand] the margins uniformly in all directions, probably overirradiating normal lung tissue." The tailored margins may, in turn, reduce the adverse effects of radiation therapy, according to Mr. Caggiano. Acknowledging the small study size, he noted that "patients who have gone through this protocol seem to have much less respiratory compromise going out from radiation therapy onward-a good indicator that this is probably a good technique to use for them." A comparison of the treatment plans generated from the ungated and gated PET/CTs revealed that gating also helped to ensure that all of the tumor was targeted, especially edges lying in the main direction of motion, Mr. Caggiano commented. "Even with good standard margins on the ungated field, there are cases when the tumor moves a lot and traverses in and out of the path of the ray...So you would be missing superior and inferior segments of the tumor and the patient would get less dose," he explained. According to Mr. Caggiano, the investigators plan to continue developing their 4D PET/CT process. One area that they will be looking at in particular is the consistency of tumor motion from day to day during treatment for lung cancer. "PET/CT is a field ripe for research right now he concluded. There are many adjustments that could be made to make it better."

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

To earn CME credit, go to
www.cancernetwork.com/cme




An Annual Review of Lung Cancer


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • Skin Lesions
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy